Search:
 
BioEnterprise
Recent News

» QED Ranked 13th Fastest-Growing Healthcare Company in US
» ViewRay Raises $20 Million
» Mork Process Raises Series B Funding
» Syncro Medical Raises Additional Funds
» ChanRx Receives Seed Investment
» Explorys Raises $2.55 Million; Texas VC Leads Round
» Clayton Dubilier & Goldman Sachs to Acquire Edgepark Medical for $850 Million



Commercialized Products & Services


Syncro Blue Tube
One of the many health care innovations brought to market by client companies.
» View More



Exit Companies



Since 2002, 21 Cleveland-area health care companies have had successful exits.
» View More



Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
Companies > Preclinical
print
Cell Targeting is developing a family of novel homing peptides to enhance targeting of therapeutic cells to specific tissues or organs. The company’s technology has both clinical and research applications with a portfolio of 15 target organs and tissues.


Funders:
Toucan Ventures, DARPA
 
Copyright © 2010 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999